Intelligent Bio Solutions Inc. 8-K Report Insights – December 2024

Here are the key insights from the provided section of the financial report:

1. Entity Information:

• Company Name: Intelligent Bio Solutions Inc.
• CIK (Central Index Key): 0001725430
• SEC File Number: 001-39825
• EIN (Employer Identification Number): 82-1512711
• Address: 135 West 41st Street, 5th Floor, New York, NY 10036
• Contact Number: (646) 828-8258
• Stock Ticker: INBS
• Exchange: NASDAQ

2. Document Type:

• Filing Type: 8-K (Current Report)

3. Filing Date:

• Date of the Report: December 18, 2024

4. Financial Metrics:

• Common Stock: The par value is $0.01.
• Reporting Currency: USD (U.S. Dollars).

5. Contextual Information:

• The reporting period is for a single day, specifically December 18, 2024, indicating this report likely contains significant or immediate events relevant to investors.

6. Units of Measurement:

• Financial amounts are reported in USD.
• Shares are reported as a separate measurement unit.

Insights:

• The company is publicly traded on NASDAQ, indicating it is subject to SEC regulations and disclosure requirements.
• The 8-K filing suggests that the company is reporting a significant event that occurred on the specified date, which is critical for investors.
• The reporting of par value suggests the company's stock has a low nominal value, which may reflect its growth stage or capital structure strategy.
• The detailed contact information provided may indicate a focus on transparency and investor relations.

This data can be crucial for investors and analysts looking to assess the company's current status, compliance with regulatory requirements, and potential investment opportunities.